Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2020 | NKG2D CAR T-cells & soluble NKG2D ligands

Antonio Pérez-Martínez • 2 Oct 2020
EBMT 2020
General CAR-T

Antonio Pérez-Martínez, MD, PhD, Hospital Universitario La Paz, Madrid, Spain, discusses his talk from the 2020 EBMT meeting outlining NKG2D CAR T-cells and how they are not affected by soluble NKG2D ligands. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Antonio Pérez-Martínez

Managing pediatric patients with B-ALL: treatment strategies & advice for physicians
2:15
Managing pediatric patients with B-ALL: treatment strategies & advice for physicians
Antonio Pérez-Martínez • 24 Mar 2026
Graft manipulation in the PTCy-era
1:53
Graft manipulation in the PTCy-era
Antonio Pérez-Martínez • 24 Mar 2026
Beyond CD19: the potential of tandem CD19/CD22 CAR T-cells in high-risk B-ALL
1:12
Beyond CD19: the potential of tandem CD19/CD22 CAR T-cells in high-risk B-ALL
Antonio Pérez-Martínez • 24 Mar 2026
Novel dual-targeting CD19/22 CAR-T therapy in relapsed ALL
1:33
Novel dual-targeting CD19/22 CAR-T therapy in relapsed ALL
Antonio Pérez-Martínez • 23 Apr 2023

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals